Phyto Kemo Agung Farma is primarily engaged in medicinals and botanicals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1984. Founded by a group of visionary entrepreneurs, Phyto Kemo Agung Farma has established itself as a prominent player in the pharmaceutical industry in Indonesia. The company focuses on the development, production, and distribution of high-quality medicinal and botanical products, catering to both domestic and international markets. Phyto Kemo Agung Farma's primary business line is the manufacturing of pharmaceutical products, with a secondary focus on the research and development of herbal medicines. The company operates several branches across Indonesia, ensuring a strong local presence and accessibility to its products. The company's product portfolio includes a wide range of pharmaceuticals, such as antibiotics, analgesics, and vitamins, as well as herbal supplements and traditional medicines. Some of their well-known brands include PhytoCure and AgungHerb, which are popular among consumers for their efficacy and quality. Phyto Kemo Agung Farma has expanded its operations beyond Indonesia, exporting its products to several countries in Southeast Asia and the Middle East. The company has also formed strategic partnerships with international pharmaceutical firms to enhance its research capabilities and product offerings. As a member of various pharmaceutical associations, Phyto Kemo Agung Farma is committed to adhering to international standards and regulations, ensuring the safety and effectiveness of its products. The company's mission is to improve the health and well-being of communities by providing innovative and affordable healthcare solutions.
Headquarters
Jl. Mesjid No. 90
East Jakarta; Jakarta;
Postal Code: 13750
Contact Details: Purchase the Pt Phyto Kemo Agung Farma report to view the information.
Website: http://www.phytokemo.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service